IL6 and Hyperglycemia: Additionally, our results showed that BA treatment significantly ameliorated hyperglycemia-mediated NFκB p65 transcriptional activation [51], subsequently decreasing the release of pro-inflammatory cytokines, including IL1β, IL6 and MCP1 [24].